1. Home
  2. EBF vs ENTA Comparison

EBF vs ENTA Comparison

Compare EBF & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ennis Inc.

EBF

Ennis Inc.

HOLD

Current Price

$19.81

Market Cap

498.3M

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.50

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBF
ENTA
Founded
1909
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
498.3M
486.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
EBF
ENTA
Price
$19.81
$13.50
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
194.6K
235.8K
Earning Date
12-22-2025
02-09-2026
Dividend Yield
5.05%
N/A
EPS Growth
5.01
N/A
EPS
1.66
N/A
Revenue
$388,740,000.00
$65,324,000.00
Revenue This Year
$0.11
$0.99
Revenue Next Year
$2.27
$0.19
P/E Ratio
$11.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.30
$4.09
52 Week High
$22.01
$17.15

Technical Indicators

Market Signals
Indicator
EBF
ENTA
Relative Strength Index (RSI) 67.92 51.15
Support Level $18.87 $12.45
Resistance Level $19.44 $13.03
Average True Range (ATR) 0.41 0.61
MACD 0.03 0.06
Stochastic Oscillator 92.96 74.60

Price Performance

Historical Comparison
EBF
ENTA

About EBF Ennis Inc.

Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: